Crescendo Biologics Ltd.
PrivateLast Round
VC Round
Jul 24, 2023
Total Funding Raised
$179.71M
Company Overview
Crescendo Biologics Ltd. operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a VC Round in July 2023.
Crescendo Biologics Ltd. is a biotechnology company that develops novel, targeted T-cell enhancing therapeutics based on its proprietary Humabody® VH platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Crescendo Biologics Ltd. Comparables
Compare Crescendo Biologics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NovalGen | 85% | |
| Leveragen, Inc. | 81% | |
| Isogenica | 80% |
For institutional investors. Book with your work email.
Crescendo Biologics Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 24, 2023 | ||||
| Corporate Funding | Jan 10, 2022 | ||||
| Series B | Apr 30, 2018 | ||||
| VC Round | Dec 16, 2014 | ||||
| Series A | Apr 3, 2014 | ||||
Series A | Dec 17, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Crescendo Biologics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | VC Round |
| IP Group | VC Round, Series B |
| Andera Partners | VC Round, Series B |
| Kreos Capital | VC Round |
| Imperial Innovations | Series A |
| UK Innovation & Science Seed Fund | Seed |
| Imperial Innovations | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2023
$32M raised with participation from Andera Partners and Kreos Capital.
- Jan 10, 2022
$40M round led by BioNTech SE
For institutional investors. Book with your work email.
Crescendo Biologics Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Crescendo Biologics Ltd.'s valuation, stock price, and market status.
Is Crescendo Biologics Ltd. a public or private company?
Crescendo Biologics Ltd. is a private company.
What is the current stock price of Crescendo Biologics Ltd.?
Crescendo Biologics Ltd. is a private company, so its shares have no public market price. Caplight tracks Crescendo Biologics Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Crescendo Biologics Ltd. worth (valuation)?
Valuation information for Crescendo Biologics Ltd. is not publicly available.
Can I buy Crescendo Biologics Ltd. stock?
Crescendo Biologics Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Crescendo Biologics Ltd.'s last funding round?
Crescendo Biologics Ltd.'s most recent funding round was VC Round on July 24, 2023.
Who are the main investors in Crescendo Biologics Ltd.?
Key investors in Crescendo Biologics Ltd. include Andera Partners, Imperial Innovations, Imperial Innovations, Sofinnova Partners.
Will Crescendo Biologics Ltd. IPO soon?
No public IPO plans have been announced for Crescendo Biologics Ltd..
How can I track Crescendo Biologics Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Crescendo Biologics Ltd.'s shares on secondary markets.